Abstract:Orofacial granulomatosis (OFG) is the presence of persistent enlargement of the soft tissues of the oral and maxillofacial region, characterized by non-caseating granulomatous inflammation in the absence of diagnosable systemic Crohn's disease (CD) or sarcoidosis. Over 20 years have passed since OFG was first described and an extensive review of the literature reveals that there is no consensus whether OFG is a distinct clinical disorder or an initial presentation of CD or sarcoidosis. Furthermore, the precise… Show more
“…OFG is a rare granulomatous disorder, characterized by persistent enlargement of the soft tissues of the oral and maxillofacial region 3 . Recurrent facial swelling, with/without intraoral manifestations, was the single most common presentation at onset 4 .…”
Section: Discussionmentioning
confidence: 99%
“…The nomenclature of OFG lacks specificity 3 . Recently, a question has been posed to determine whether OFG is a manifestation of a separate and specific inflammatory bowel disease 5 .…”
“…OFG is a rare granulomatous disorder, characterized by persistent enlargement of the soft tissues of the oral and maxillofacial region 3 . Recurrent facial swelling, with/without intraoral manifestations, was the single most common presentation at onset 4 .…”
Section: Discussionmentioning
confidence: 99%
“…The nomenclature of OFG lacks specificity 3 . Recently, a question has been posed to determine whether OFG is a manifestation of a separate and specific inflammatory bowel disease 5 .…”
“…21 OFG is a rare clinical entity manifest by lymphoedema of the face and oral cavity and shares many of the histological characteristics of AGG. 22 OFG is also reported to overlap with intestinal CD in 20-40% of cases. 18,23 Notably in our series, four patients had OFG, 2 of whom had a triad of AGG,OFG and CD.…”
Section: Findings In Relationship To Other Studiesmentioning
“…When associated with fissured tongue and facial nerve palsy, it is named Melkersson-Rosental syndrome [3] . Moreover, OFG may represent the earliest manifestation of Crohn's disease, a granulomatous condition that can affect any part of the gastrointestinal tract [4,5,[7][8][9] .…”
Objective: The aim of this paper was to report a case of orofacial granulomatosis, with immunohistochemical evaluation of some inflammatory cells that would be involved on its etiopathogenesis.
Methods:The specimen was collected through biopsy for diagnostic proposal and was further submitted to immunohistochemistry for CD3, CD20, S-100, D2-40, and AE1/AE3. Immunohistochemical analysis was performed in inflammatory cells in granulomatous nodules and through the oral mucosa.
Results:In the granulomas, CD3+ cells were the main component of inflammatory cells. S-100+ cells were seen diffusely distributed. CD20+ cells were observed in a lower amount than CD3+ and S-100+. D2-40 staining evidenced some large lymphatic vessels, which were surrounded by inflammatory cells. Besides the granulomas, an intense and diffuse inflammatory infiltrate was seen in connective tissue, immediately below the epithelium with a large number of CD3+ cells in intimate contact. A disorganization of the basal layer of epithelium was also present. AE1/AE3 was positive only in the keratinocytes. S-100+ cells were numerous in the connective tissue, and infiltrating the epithelium. CD20+ cells were observed in a lower number than CD3+ and S-100+, mainly located in a deeper region of the connective tissue.Conclusions: Dendritic cells and T lymphocytes were the major components of inflammatory infiltrate in oral mucosa and granulomatous nodules. The observed epithelial disorganization was quite similar to that of lichen planus. The findings corroborate to a cell-mediated immunological background of orofacial granulomatosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.